Register to use all the features of this website, including selecting clinical areas of interest and “favourite” articles, taking part in quizzes and much more.
Hint: If you are a General Practitioner your username may be your MCNZ#
About us | FAQ | Contact us | Terms of use
Interactive quizzes are based on material found in Best Practice Journal and Best Tests. Initially, quizzes are posted out with journals and GPs are invited to submit their answers for CME credits.
Register or Log in to take part in quizzes.
Login to my bpac.
Don't have an account? Register to use all the features of this website, including selecting clinical areas of interest, taking part in quizzes and much more.
Follow-up and surveillance of patients who have undergone curative-intent treatment for gynaecological cancer is an opportunity... View Article
Vaginal cancer is the least common type of gynaecological cancer in New Zealand with an average of 17 females newly diagnosed... View Article
Vulval cancer is a rare gynaecological cancer in New Zealand, with an average of 52 females newly diagnosed each year (from 2015... View Article
Uterine cancer is the most prevalent gynaecological cancer in New Zealand, with an average of 627 females newly diagnosed each... View Article
Ovarian cancer is the second most common gynaecological cancer in New Zealand after endometrial cancer, with an average of 371... View Article
The risk of cervical cancer is significantly reduced through HPV vaccination and cervical screening programmes, however, there... View Article
Transitioning from active treatment to post-treatment care is an important milestone in the long-term health of people who have... View Article
Guidance for following up people who have had polyps identified on colonoscopy and people with inflammatory bowel disease, who... View Article
Bowel cancer is a leading cause of cancer mortality in New Zealand, second only to lung cancer. Follow-up and surveillance of... View Article
Through improvements in diagnosis and treatment, one in three people in New Zealand with cancer now achieve sustained remission... View Article
Lung cancer is one of the most common cancers in New Zealand and the leading cause of cancer death. By the time of diagnosis,... View Article
This report provides an overview of laboratory prostate-specific antigen (PSA) testing in primary care to facilitate reflection,... View Article
Bowel cancer is one of the most common causes of cancer death in New Zealand. Approximately one-quarter of diagnoses are made... View Article
Testing for prostate cancer is a difficult issue as many prostate cancers are low risk and do not necessarily result in adverse... View Article
The following questions can be used as discussion points for peer groups or self-reflection of practice. The questions for this... View Article
Limiting UV radiation exposure through sun smart behaviour is the key to preventing melanoma. However, incidence and mortality... View Article
Identification of melanoma at the earliest possible clinical stage improves outcomes; lesion thickness is the strongest predictor... View Article